| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 1 1-6, Copyright © 1990 by American Association of Immunologists
ARTICLES |
V David, H Bachelez, G Leca, L Degos, L Boumsell and A Bensussan
Hopital Saint-Louis, INSERM U93, Paris, France.
A small percentage of circulating CD3+ cells express a heterodimeric gamma delta receptor. Most of these cells do not express the surface marker CD4 and only a fraction of them bear CD8 molecules. The specificity and function of TCR-gamma delta are unclear. We obtained a murine mAb produced against an IL-2-dependent human T cell clone defining a novel molecule sTA which is not expressed on resting human peripheral blood CD3+ cells but strongly expressed on a fraction of TCR- gamma delta-bearing clones. Like receptors for growth factors such as IL-2, the sTA Ag is present on clones and cell lines according on the cell cycle. SDS-PAGE analysis of sTA immunoprecipitates from 125I- labeled sTA+ clone lysate demonstrated a single band of molecular mass 110 kDa under reducing conditions. Triggering with anti-sTA mAb did not result in [Ca2+]i mobilization of sTA+ clones. Additionally, the presence of anti-sTA did not alter the cytotoxicity of these sTA+ clones neither against tumor target cells nor against specific PHA blast cells. Interestingly, due to the fact that most sTA+ clones fail to proliferate in response to CD3 triggering, it appears that sTA may serve as a useful marker to study the functional heterogeneity of TCR- gamma delta expressing cells.
This article has been cited by other articles:
|
|
 |
|
  E. Poszepczynska, M. Bagot, H. Echchakir, D. Martinvalet, M. Ramez, D. Charue, L. Boumsell, and A. Bensussan Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma Blood, August 1, 2000; 96(3): 1056 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Dalakas Mechanism of Action of Intravenous Immunoglobulin and Therapeutic Considerations in the Treatment of Autoimmune Neurologic Diseases Neurology, December 1, 1998; 51(6_Suppl_5): S2 - S8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Y. Wang, D. K. Okita, J. Howard Jr., and B. M. Conti-Fine T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis Neurology, April 1, 1998; 50(4): 1045 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Clark Cytokines and reperfusion injury Neurology, November 1, 1997; 49(5_Suppl_4): S10 - S14. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Elhabazi, V. Lang, C. Herold, G. J. Freeman, A. Bensussan, L. Boumsell, and G. Bismuth The Human Semaphorin-like Leukocyte Cell Surface Molecule CD100 Associates with a Serine Kinase Activity J. Biol. Chem., September 19, 1997; 272(38): 23515 - 23520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Brod, G. D. Marshall Jr., E. M. Henninger, S. Sriram, M. Khan, and J. S. Wolinsky Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis Neurology, June 1, 1996; 46(6): 1633 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-P. Hartung, J. J. Archelos, J. Zielasek, R. Gold, M. Koltzenburg, K.-H. Reiners, and K. V. Toyka Circulating adhesion molecules and inflammatory mediators in demyelination: A review Neurology, June 1, 1995; 45(6_Suppl_6): S22 - S32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Selmaj and C. S. Raine Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors Neurology, June 1, 1995; 45(6_Suppl_6): S44 - S49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gemmell and G. J. Seymour Cytokines and T Cell Switching Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 249 - 279. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
